Funding for this research was provided by:
Received: 6 December 2021
Revised: 12 April 2022
Accepted: 11 May 2022
First Online: 30 May 2022
: TJ, GMT, CD, DS, IC, and MP are employees of Astrazeneca, UK. JC is an employee of Asklepios Biopharmaceutical, Inc. EAC is an Astrazeneca sponsored postdoctoral fellow & DKS and SW are collaborators working at the University at Buffalo.